Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept for PCV (STAR Extension)
NCT03244657Phase 4Unknown
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Apr 2017
- Primary completion
- Oct 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of conbercept in polypoidal choroidal vasculopathy (PCV), sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Status: unknown.
02
Drugs
conbercept
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT03244657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03244657.